immunomodulatory drug


Also found in: Acronyms.

immunomodulatory drug

Clinical pharmacology A therapeutic agent that suppresses the immune system, inhibiting lymphocyte functions, especially T and NK cells; IDs are used to treat IBD–ulcerative colitis, Crohn's disease Examples Azathioprine, mercaptopurine Adverse effects BM suppression, pancreatitis; ↑ lymphoma; cyclosporine Adverse effects Renal dysfunction; MTX Adverse effects BM suppression, liver toxicity
References in periodicals archive ?
The contract is: Delivery of antibiotics, general, cytostatic, anti-tuberculosis, immunomodulatory drugs, narcotic drugs, psychotropic drugs imported target fluids for intravenous infusion, serums and vaccines, preparations for parenteral nutrition, dojelitego, pharmaceutical raw materials.
The contract is: Delivery of antibiotics, general, cytostatic, antituberculosis, immunomodulatory drugs, narcotic drugs, psychotropic drugs imported target fluids for intravenous infusion, irrigation liquids, lotions, hemofiltration, serums and vaccines, contrast agents, preparations for feeding parenteral, enteral and oral supply kits for enteral nutrition, pharmaceutical raw materials, material articles.
A new class of topical immunomodulatory drugs has proved to be highly effective for the treatment of atopic dermatitis in adults, but long-standing agents still have a role in treating the so-called itch that rashes.
REVLIMID from the Celgene Corporation with headquarters in New Jersey in the United States and Neuchatel in Switzerland, is an oral medication belonging to a new class of immunomodulatory drugs called IMiDs(R).
cCAM Biotherapeutics, a biopharmaceutical company focused on the discovery and development of novel immunomodulatory drugs for cancer, announced today the completion of its Series A financing.
A dramatic change is underway in the treatment practice for multiple myeloma as old style chemotherapy regimens are being abandoned in favor of recently approved immunomodulatory drugs and proteasome inhibitors.
REVLIMID is a member of a proprietary group of novel immunomodulatory drugs, or IMiDs.
Anderson has organized, chaired, and spoken at international conferences focused on discovery and development of novel anti- inflammatory and immunomodulatory drugs.
REVLIMID is a member of a new class of novel IMiDs(R), immunomodulatory drugs.
Symptomatic treatment with simple corticosteroids, androgens, immunomodulatory drugs and cytotoxic agents is used but only to relieve the associated symptoms, such as anemia, splenomegaly, fever and sweating during sleep.
Immunetrics, with a mission to become a leading company in inflammatory disease modeling, leverages its technology to develop a pipeline of immunomodulatory drugs.